Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study highlights on the biochemical and immunological analysis of
MS-KIF18A
in pre-osteogenic MBA-15 cells. The protein distribution in various cellular compartments was demonstrated by imaging and Western blot (WB) analysis.
MS-KIF18A
interactions with cytoskeletal proteins were confirmed for tubulin and actin. The complex between
MS-KIF18A
and microtubules (MT) was demonstrated in cellular system for endogenous proteins and also between recombinant proteins in pull down and immunoprecipitation (IP) assays. Multiple assays including metabolic labeling, cell fractionation and IP with anti-
MS-KIF18A
antibody demonstrated an association with actin that was prominent in the cell cytoplasm. Sub-cellular fractionation identified diverse forms of
MS-KIF18A
in cytoplasm and membrane/nucleus compartments which are suggested to represent the result of post-transcriptional modifications, such as phosphorylation and glycosylation. These modifications on
MS-KIF18A
were analyzed by bioinformatics and immunological assays. Furthermore, we studied the role of ubiquitin-
proteasome
system in the
MS-KIF18A
degradation. Taken together, the current study sheds light on
MS-KIF18A
a MT-dependent kinesin and adds insights on the post-translational modifications that potentially control the protein cellular distribution and its co-association with cytoskeletal proteins.
...
PMID:New insights on cellular distribution, microtubule interactions and post-translational modifications of MS-KIF18A. 1868 Jan 69